Navigation Links
FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data
Date:3/17/2008

Eventually, these problems may cause life-threatening complications, such as overwhelming infections and fatal bleeding. More information about CLL can be accessed at the website for the Lymphoma Research Foundation at: http://www.lymphoma.org.

About Genasense

Genasense inhibits production of Bcl-2, a protein made by cancer cells that is thought to block chemotherapy-induced apoptosis (programmed cell death). By reducing the amount of Bcl-2 in cancer cells, Genasense may enhance the effectiveness of current anticancer treatment. Genta is pursuing a broad clinical development program with Genasense evaluating its potential to treat various forms of cancer.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. The Company has developed G4544, an oral formulation of the active ingredient in Ganite, that has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss. The Company is also developing Tesetaxel(R), a novel, orally absorbed, semi- synthetic taxane that is in the same class of drug as paclitaxel and docetaxel. Ganite and Genasense are available on a "named-patient" basis in countries outside the United States
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia
2. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
3. Genasense(R) Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress
4. Genasense(R) Can be Administered by Brief High-Dose IV Infusion
5. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent
9. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
10. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
11. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015 CANTEL MEDICAL CORP. (NYSE: ... ended January 31, 2015 on Thursday, March 12 before the ... results at 11:00 AM ET. To participate ... 10 minutes before the beginning of the call. If you ... will be available from Thursday, March 12, 2015 through midnight ...
(Date:3/5/2015)...   AMC Health , the leading provider ... the effectiveness and efficiency of healthcare for high-risk ... and Jared Wilstead have joined the ... Client Development, and Wilstead will serve as Vice ... commitment to accelerating the adoption of monitored care ...
(Date:3/5/2015)... Minn. , March 5, 2015  ANI ... today announced that it has acquired the approved ... tablets USP 50mg, 100mg and 150mg, previously marketed ... overall market for this product was approximately $39 ... S. Przybyl , President and CEO of ANI ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 2ANI Pharmaceuticals Acquires Generic Drug Product from Teva Pharmaceuticals 3
... What if there,s a fall, and you aren,t able to press ... wearable, medical alarm that sends an automatic alert- no need to ... increasing demand for its automatic fall detection. More caregivers and families ... are not effective in the event of an emergency, and are ...
... SOUTH JORDAN, Utah, Oct. 11, 2011 Merit Medical ... manufacturer and marketer of proprietary disposable medical devices used ... and endoscopy, announced today that the Company will release ... 30, 2011, after the close of the stock market ...
Cached Medicine Technology:myHalo Grows as Automatic Fall Detection Becomes a Must-Have 2
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 A Bakersfield, ... a seven-week trial awarding the plaintiff Coleen M. ... as a result of a TVT-Abbrevo pelvic mesh sling device, ... , Tom Cartmell , a partner at Wagstaff ... trial team for the plaintiff, along with Rich Freese and ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Risperdal ... in a Pennsylvania mass tort litigation currently underway ... a jury has begun hearing testimony in the ... atypical antipsychotic medication can cause gynecomastia, or male ... in question was filed on behalf of a ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased ... brand’s new logo and optimized website. , ... approach to expert diagnostic imaging, centered on patient care. ... to be a resource for Nebraska patients and a ... communication and referral functionality, video content and resources to ...
(Date:3/5/2015)... 05, 2015 HomeCEUConnection.com is ... with extra savings on their nutrition CEUs. ... health and nutrition, HomeCEUConnection.com is offering 10% ... promo code, NUTRITION2015 . , High ... , HomeCEUConnection.com provides high-quality continuing education courses ...
(Date:3/5/2015)... On March 2, 2015, NBC News ... the Rise, Plastic Surgeons Say,” that comments on the ... Aesthetic Plastic Surgery and the American Society ... year-over-year doubling of surgical butt augmentations performed in 2014. ... article, this increase can be attributed to the social ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2
... (HealthDay News) -- Modern humans first left Africa much earlier ... toolkit with hand axes, scrapers and perforators resembling those crafted ... Middle East -- was found in the United Arab Emirates, ... to 125,000 years, researchers said the finding indicates that humans ...
... News) -- Arizona Congresswoman Gabrielle Giffords began intensive rehabilitation ... the lawmaker who was shot in the brain earlier ... Hospital could last several months. As a first move, ... valve into her breathing tube, the Associated Press ...
... Medicine and Dentistry (PCMD), University of Exeter, is one of ... 6m research and analysis network, funded by the EU for ... role of virus infection in the cause of type 1 ... the development of a vaccine to prevent diabetes in children. ...
... University School of Dentistry department chair with researchers from ... and creative solutions to address the growing scarcity of ... The report cites widening pay gaps between private ... one factor in fewer dentists committing to careers in ...
... , THURSDAY, Jan. 27 (HealthDay News) -- Only 42 ... and can therefore be categorized as "great sleepers," according to ... Poll" found that great sleepers get an average of about ... sleeper gets an average of seven hours and nine minutes ...
... , THURSDAY, Jan. 27 (HealthDay News) -- Work-related hearing ... found. Israeli researchers gave hearing tests to 298 male ... noise and found that 99 of the workers had a ... problems tended to be older and to have been exposed ...
Cached Medicine News:Health News:Ancient Toolkit Holds Clues to Migration of Early Man 2Health News:Rep. Giffords' Intensive Rehab Under Way 2Health News:Rep. Giffords' Intensive Rehab Under Way 3Health News:6 million euros for European Diabetes Research Network 2Health News:Report offers solutions to address decline in US dental faculty 2Health News:Loving Your Bedroom May Be Key to Good Sleep 2
Make better prescribing decisions with this drug interaction analyzer containing over 3,000 brand names with generic equivalents....
... Drug Guide for Physicians ... 760 Integrated Calculators - ... up-to-date and practical drug ... drug dosing calculation tools ...
AnesthesiaDrugs™ is the handheld version of Sota Omoigui's Anesthesia Drugs Handbook, the best selling clinical guide to essential anesthesia and critical care drug information....
... to use drug information reference ... protocols with patient care guidelines., ... more than 4,700 drugs, including ... the latest indications, dosages, side ...
Medicine Products: